Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;

NCT04290494 · clinicaltrials.gov ↗

COMPLETED

Status

42188

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: IV rtPA (intravenous recombinant plasminogen activator)

Sponsor

Boehringer Ingelheim